SL Science Holding Limited filed a Form 6-K on November 3, 2026, disclosing that Dr. Ethan Shen resigned as director and Chief Technology Officer effective November 1, 2026, and that the board simultaneously appointed Dr. Chin-Sheng Hung as director and Chief Medical Officer on the same date.

Key Highlights

  • Resignation effective November 1, 2026: Dr. Ethan Shen stepped down from his roles as director and Chief Technology Officer of SL Science Holding Limited.
  • No disagreement cited: According to the filing, Dr. Shen's resignation "was not due to any disagreement with the Company on any matter relating to the Company's operations, policies, or practices."
  • New appointment: The board appointed Dr. Chin-Sheng Hung as director and Chief Medical Officer, also effective November 1, 2026.
  • Incoming CMO's current role: Since July 2025, Dr. Hung has served as Director of the Medical Administration Department at Taipei Medical University Hospital.
  • Prior surgical leadership: Dr. Hung served as Chief of Surgery at Taipei Medical University Hospital from July 2021 to July 2025, and as Chief of Surgery at Shuang-Ho Hospital-Taipei Medical University from August 2018 to June 2021.
  • Academic credentials: Dr. Hung holds a Bachelor of Medicine and a Master in Clinical Medicine from National Taiwan University, and a Ph.D. from the Graduate Institute of Clinical Medicine, Taipei Medical University.

Leadership Transition at SL Science Holding Limited: CTO Departs, CMO Appointed

SL Science Holding Limited (NASDAQ:SLBT) reported a leadership change at the board and executive level through a Form 6-K filed with the U.S. Securities and Exchange Commission on November 3, 2026. According to the filing, Dr. Ethan Shen submitted his resignation from both his directorship and his position as Chief Technology Officer, with the board accepting the resignation effective November 1, 2026. The filing explicitly states that the departure was not related to any disagreement with the company over its operations, policies, or practices.

On the same date, the board appointed Dr. Chin-Sheng Hung to serve as a director and as the company's Chief Medical Officer, the filing disclosed. Dr. Hung's background, as described in the filing, spans surgery, physician training and education, departmental management, and hospital administration. His most recent position, held since July 2025, is Director of the Medical Administration Department at Taipei Medical University Hospital, where his responsibilities cover medical and surgical affairs, physician training and education, and hospital management.

Before that role, the filing notes, Dr. Hung was Chief of Surgery at Taipei Medical University Hospital from July 2021 to July 2025, and Chief of Surgery at Shuang-Ho Hospital-Taipei Medical University from August 2018 to June 2021. The company is a foreign private issuer and files annual reports under Form 20-F, according to the filing. The Form 6-K is incorporated by reference into the company's Form S-8 registration statement (Registration No. 333-299394), to the extent not superseded by subsequent filings.

What Was Disclosed

SL Science Holding Limited disclosed the November 1, 2026, resignation of director and CTO Dr. Ethan Shen and the concurrent appointment of Dr. Chin-Sheng Hung as director and Chief Medical Officer, along with Dr. Hung's professional and academic background.